Emergency Medical Caution
If you or someone you are caring for is experiencing an acute, life-threatening adverse reaction, please seek immediate emergency care or visit the nearest hospital emergency unit before completing this regulatory report.
Pharmacovigilance (ADR Reporting)
G.D. Pharmaceuticals is committed to patient safety throughout the complete lifecycle of our therapeutics. Every adverse drug reaction (ADR) report is evaluated by our Clinical Safety & Vigilance Department under Department of Drug Administration (DDA) guidelines.
Vigilance Hotline
Medical professionals and hospital pharmacists may reach out directly to our 24/7 designated pharmacovigilance officer:
Regulatory Framework
Adverse reactions collected through this portal are processed under the Drug Act 2035 (Nepal), DDA National Pharmacovigilance Centre guidelines, and WHO Uppsala Monitoring Centre (UMC) international safety protocols.